跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lanozol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lanozol
Approved
STANDARD
Lanozol
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
27e527e5e1224119
Company
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
27e527e5e1224119
Drug Approval Philippines Name
Lanozol
Product Name
Lanozol
Registration Number
DR-XY45020
Brand Name
Lanozol
Generic Name
Lansoprazole
Dosage Form
Delayed-Release Capsule
Dosage Strength
30 mg
Manufacturer
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 January 2016
Expiry Date
28 January 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
27e527e5e1224119
Type
Standard
Back to Philippines FDA Approvals